Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Children | 1 |
| Developmental Stages | 1 |
| Drug Therapy | 1 |
| Mental Disorders | 1 |
| Outcomes of Treatment | 1 |
| Patients | 1 |
| Pediatrics | 1 |
| Schizophrenia | 1 |
| Symptoms (Individual… | 1 |
Source
| Journal of the American… | 1 |
Author
| Findling, Robert L. | 1 |
| Frazier, Jean A. | 1 |
| Gerbino-Rosen, Ginny | 1 |
| Kranzler, Harvey N. | 1 |
| Kratochvil, Christopher J. | 1 |
| Kumra, Sanjiv | 1 |
Publication Type
| Journal Articles | 1 |
| Opinion Papers | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkFindling, Robert L.; Frazier, Jean A.; Gerbino-Rosen, Ginny; Kranzler, Harvey N.; Kumra, Sanjiv; Kratochvil, Christopher J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
This article presents responses to the question of whether clozapine is ever appropriate to use in the pediatric population. Among others, Jean A. Frazier also agreed that clozapine is appropriate for use in the pediatric population. Clozapine has truly revolutionized the treatment of refractory patients with schizophrenia at any age. This agent…
Descriptors: Patients, Adolescents, Schizophrenia, Pediatrics
